JCOGP
Journal of Controversies in Obstetrics & Gynecology and Pediatrics

As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
The intersection of technology and infertility: pioneering approaches in genetic editing and artificial intelligence
Abstract
Infertility, a global health concern, impacts millions of individuals and couples, entailing profound emotional and socio-economic consequences. Recent advances in genetic editing and artificial intelligence (AI) herald a new frontier in infertility treatment, offering precision, personalization, and enhanced efficacy. This compilation explores the integration of clustered regularly interspaced short palindromic repeats associated proteins (CRISPR-Cas) 9 gene editing and AI-driven diagnostics and treatment strategies in the context of reproductive medicine. Through a comprehensive review of current research, clinical applications, and ethical considerations, this paper highlights the transformative potential of these technologies while addressing the associated challenges. The synergy of genetic editing and AI not only promises to improve outcomes for individuals battling infertility but also raises important questions about accessibility, privacy, and ethical implications. By examining these developments, we aim to provide insights into the future of infertility treatments and the evolving landscape of reproductive medicine.

Keywords : Infertility, genetic editing, CRISPR-Cas9, artificial intelligence, reproductive medicine

Download Article


1. World Health Organization. Global prevalence of infertility,infecundity, and childlessness. 2021;(123):4-8
2. Ombelet W, Van Robays J. Artificial insemination history: hurdlesand milestones.Facts Views Vis Obgyn. 2015;7(2):137-143.
3. Doudna JA, Charpentier E. Genome editing. The newfrontier of genome engineering with CRISPR-Cas9.Science.2014;346(6213):1258096. doi: 10.1126/science.1258096
4. Rolfes V, Bittner U, Gerhards H, et al. Artificial intelligencein reproductive medicine-an ethical perspective.GeburtshilfeFrauenheilkd. 2023;83(1):106-115. doi: 10.1055/a-1866-2792
5. World Health Organization. Infertility Definitions andTerminology. 2020;(35):2735-2745
6. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA,Charpentier E. A programmable dual-RNA-guided DNAendonuclease in adaptive bacterial immunity.Science.2012;337(6096):816-821.
7. Zhu P, Wu F, Mosenson J, Zhang H, He TC, Wu WS. CRISPR/Cas9-mediated genome editing corrects dystrophin mutationin skeletal muscle stem cells in a mouse model of muscledystrophy.Mol Ther Nucleic Acids. 2017;(7):31-41. doi: 10.1016/j.omtn.2017.02.007
8. Ma H, Marti-Gutierrez N, Park SW, et al. Correction ofa pathogenic gene mutation in human embryos.Nature.2017;548(7668):413-419. doi: 10.1038/nature23305
9. National Academies of Sciences, Engineering, and Medicine;National Academy of Medicine; National Academy of Sciences;Committee on Human Gene Editing: Scientific, Medical, andEthical Considerations. Human Genome Editing: Science, Ethics,and Governance. National Academies Press. 2017;(14):28796468.
10. Fu Y, Foden JA, Khayter C, et al. High-frequency off-targetmutagenesis induced by CRISPR-Cas nucleases in humancells.Nat Biotechnol. 2013;31(9):822-826. doi: 10.1038/nbt.2623
11. Lin B, Ma Y, Wu S. Multi-omics and artificial intelligence-guided data integration in chronic liver disease: prospects andchallenges for precision medicine.OMICS. 2022;26(8):415-421.doi: 10.1089/omi.2022.0079
12. Medenica S, Zivanovic D, Batkoska L, et al. The future iscoming: artificial intelligence in the treatment of infertility couldimprove assisted reproduction outcomes-the value of regulatoryframeworks.Diagnostics. 2022;12(12):2979. doi: 10.3390/diagnostics12122979
13. Hanassab S, Abbara A, Yeung AC, et al. The prospect of artificialintelligence to personalize assisted reproductive technology.NPJDigit Med. 2024;7(1):55. doi: 10.1038/s41746-024-01006-x
14. Si K, Huang B, Jin L. Application of artificial intelligence ingametes and embryos selection.Hum Fertil. 2023;26(4):757-777.
15. Wang R, Pan W, Jin L, et al. Artificial intelligence in reproductivemedicine.Reproduction. 2019;158(4):R139-R154. doi: 10.1530/REP-18-0523
16. Güell E. Criteria for implementing artificial intelligence systemsin reproductive medicine.Clin Exp Reprod Med. 2024;51(1):1-12.doi: 10.5653/cerm.2023.06009
17. Arnold MH. Teasing out artificial intelligence in medicine: anethical critique of artificial intelligence and machine learning inmedicine.J Bioeth Inq. 2021;18(1):121-139. doi: 10.1007/s11673-020-10080-1
18. Collins FS, Varmus H. A new initiative on precision medicine.NEngl J Med. 2015;372(9):793-795. doi:10.1056/NEJMp1500523
19. Ishii T. Reproductive medicine involving genome editing: clinicaluncertainties and embryological needs.Reprod Biomed Online.2017;34(1):27-31. doi: 10.1016/j.rbmo.2016.09.009
20. Morshedzadeh F, Ghanei M, Lotfi M, et al. An update on theapplication of CRISPR technology in clinical practice.MolBiotechnol. 2024;66(2):179-197. doi: 10.1007/s12033-023-00724-z
21. Ishii T. Germ line genome editing in clinics: the approaches,objectives and global society.Brief Funct Genomics. 2017;16(1):46-56. doi: 10.1093/bfgp/elv053
22. Ishii T. Reproductive medicine involving genome editing: clinicaluncertainties and embryological needs.Reprod Biomed Online.2017;34(1):27-31. doi: 10.1016/j.rbmo.2016.09.009
23. Wang YL, Gao S, Xiao Q, et al. Role of artificial intelligence indigital pathology for gynecological cancers.Comput StructBiotechnol J. 2024;24:205-212. doi: 10.1016/j.csbj.2024.03.007
24. van Dijke I, Lakeman P, Mathijssen IB, Goddijn M, Cornel MC,Henneman L. How will new genetic technologies, such as geneediting, change reproductive decision-making? Views of high-risk couples.Eur J Hum Genet. 2021;29(1):39-50. doi: 10.1038/s41431-020-00706-8
25. Knoppers BM, Kleiderman E. “CRISPR babies”: what does thismean for science and Canada?CMAJ. 2019;191(4):E91-E92.
26. Khan B, Fatima H, Qureshi A, et al. Drawbacks of artificialintelligence and their potential solutions in the healthcaresector.Biomed Mater Devices. 2023;1(2):731-738. doi: 10.1007/s44174-023-00063-2
Article available in :
Volume 2, Issue 3, 2024
Page : 64-68
https://doi.org/10.51271/JCOGP-0037
Article Information
Received : 25 Mar 2024
Accepted : 15 Nis 2024
Published : 30 Tem 2024
Corresponding Author :

Tuğba Gürbüz: Department of Gynecology and Obstetric Clinic, Medistate Hospital, İstanbul, Turkiye

[email protected]
Citation : Gürbüz T, Yurci A. The intersection of technology and infertility: pioneering approaches in genetic editing and artificial intelligence. J Controv Obstetr Gynecol Ped. 2024;2(3)64-68

Read: 252
Cited: 0
Download : 132
_Footer